Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2026ACS Infectious Diseases

Biopolymer-Antigen Conjugate Vaccines for Prevention of Tularemia

View Full Paper
Ask AI
Bookmark
Share

Authors

GSGayathri SamCSCharles T. SpencerBRBernd H. A. Rehm

Discussion

Loading...

Member takes

Overview

Preclinical study demonstrates 80% survival and protective immunity in mice vaccinated with biopolymer-antigen conjugates, suggesting a viable thermostable tularemia vaccine.

Key Points

  • To develop and evaluate a safer, thermostable multivalent biopolymer-antigen conjugate subunit vaccine against Francisella tularensis.
  • Engineered Escherichia coli to produce biopolymer particles conjugated with F. tularensis antigens (FopA, Tul4, SucB, and DnaK) via single-step fermentation.
  • Assessed vaccine-induced antibody titers against LVS and SchuS4, cytokine profiles, and protective efficacy in mice challenged with the live vaccine strain (LVS).
  • Vaccination conferred 80% survival in mice upon LVS challenge, accompanied by rapid recovery from weight loss.
  • Formulation elicited robust opsonizing antibodies against LVS and SchuS4 strains alongside distinct cytokine profiles.
  • Achieved thermostable vaccine production in an E. coli system, eliminating cold-chain requirements and high-containment manufacturing.

Cite This Study

Sam et al. (2026) studied this question.

synapsesocial.com/papers/6aabb68c5f706d05830e5041https://doi.org/10.1021/acsinfecdis.6c00694
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Designing of a conserved subunit multiepitope vaccine candidate against Francisella tularensis Schu S4 using immunoinformatics2026
  2. 2A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model2024 · 4 citations
  3. 3Longitudinal phase 2 clinical trials of live, attenuated tularemia vaccine in otherwise healthy research laboratory workers operating in containment laboratories2023 · 1 citations
  4. 4Transcriptional analyses of peripheral blood lymphocytes obtained shortly after primary immunization discriminate vaccines against <i>Francisella tularensis</i>2026
  5. 5Identification of Immunological Correlates of Protection during Development of Specific Immunity to Francisella tularensis2024